| Drug Name: | Clopidogrel (113665-84-2) |
|---|---|
| PubChem ID: | 115366 |
| SMILES: | COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O |
| InchiKey: | FDEODCTUSIWGLK-RSAXXLAASA-N |
| Therapeutic Category: | Hematologic Agents, Neurotransmitter Agents, Platelet Aggregation Inhibitors, Purinergic Agents, Purinergic Antagonists, Purinergic P2 Receptor Antagonists, Purinergic P2X Receptor Antagonists, Purinergic P2Y Receptor Antagonists |
| Molecular Weight (dalton) | : | 419.908 |
| LogP | : | 3.0211 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 104.14 |
This panel provides information on interacting drugs and their ADRs along with references
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|---|---|
| Grapefruit Juice | Attenuated Antiplatelet Activity | Interactions between grapefruit juice and cardiovascular drugs |
| Grapefruit Juice | Loss Of Efficacy | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category